Dr. Benjamin Maughan, MD
NPI: 1255656120
Total Payments
$138,156
2024 Payments
$24,327
Companies
23
Transactions
195
Medicare Patients
950
Medicare Billing
$179,573
Payment Breakdown by Category
Consulting$89,109 (64.5%)
Other$27,075 (19.6%)
Travel$15,106 (10.9%)
Food & Beverage$6,785 (4.9%)
Education$80.16 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $89,109 | 39 | 64.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $17,910 | 6 | 13.0% |
| Travel and Lodging | $15,106 | 46 | 10.9% |
| Honoraria | $9,165 | 5 | 6.6% |
| Food and Beverage | $6,785 | 94 | 4.9% |
| Education | $80.16 | 5 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | $36,035 | 54 | $0 (2024) |
| PFIZER INC. | $17,004 | 15 | $0 (2024) |
| Exelixis Inc. | $14,907 | 28 | $0 (2023) |
| Janssen Scientific Affairs, LLC | $13,019 | 18 | $0 (2024) |
| Merck Sharp & Dohme LLC | $6,841 | 15 | $0 (2024) |
| Janssen Biotech, Inc. | $6,159 | 8 | $0 (2022) |
| GENZYME CORPORATION | $6,133 | 5 | $0 (2023) |
| Eli Lilly and Company | $6,025 | 7 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $5,542 | 4 | $0 (2021) |
| Janssen Global Services, LLC | $5,500 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $24,327 | 25 | Bayer Healthcare Pharmaceuticals Inc. ($9,969) |
| 2023 | $20,735 | 27 | PFIZER INC. ($8,524) |
| 2022 | $25,317 | 33 | Bayer HealthCare Pharmaceuticals Inc. ($15,135) |
| 2021 | $25,412 | 16 | PFIZER INC. ($7,909) |
| 2020 | $6,923 | 9 | Bayer HealthCare Pharmaceuticals Inc. ($1,988) |
| 2019 | $18,282 | 34 | Bayer HealthCare Pharmaceuticals Inc. ($7,153) |
| 2018 | $10,357 | 27 | Exelixis Inc. ($7,682) |
| 2017 | $6,804 | 24 | Janssen Scientific Affairs, LLC ($2,924) |
All Payment Transactions
195 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | Eisai Inc. | Lenvima (Drug) | Consulting Fee | Cash or cash equivalent | $2,205.00 | General |
| Category: Oncology | ||||||
| 12/18/2024 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $305.00 | General |
| 12/06/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $93.42 | General |
| Category: Oncology | ||||||
| 12/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Consulting Fee | Cash or cash equivalent | $2,884.00 | General |
| Category: Oncology | ||||||
| 12/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $77.75 | General |
| Category: Oncology | ||||||
| 12/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $30.19 | General |
| Category: Oncology | ||||||
| 11/11/2024 | Aveo Pharmaceuticals, Inc. | FOTIVDA (Drug) | Food and Beverage | In-kind items and services | $134.81 | General |
| Category: Oncology | ||||||
| 11/09/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $35.72 | General |
| Category: Oncology | ||||||
| 11/09/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $19.51 | General |
| Category: Oncology | ||||||
| 10/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Xofigo (Drug) | Consulting Fee | Cash or cash equivalent | $4,326.00 | General |
| Category: Oncology | ||||||
| 10/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Xofigo (Drug) | Food and Beverage | In-kind items and services | $63.71 | General |
| Category: Oncology | ||||||
| 10/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Xofigo (Drug) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: Oncology | ||||||
| 10/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Xofigo (Drug) | Food and Beverage | In-kind items and services | $36.38 | General |
| Category: Oncology | ||||||
| 10/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Xofigo (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Oncology | ||||||
| 10/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Xofigo (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Oncology | ||||||
| 10/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Xofigo (Drug) | Travel and Lodging | In-kind items and services | $5.00 | General |
| Category: Oncology | ||||||
| 10/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Xofigo (Drug) | Travel and Lodging | In-kind items and services | $226.86 | General |
| Category: Oncology | ||||||
| 10/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Xofigo (Drug) | Food and Beverage | In-kind items and services | $138.71 | General |
| Category: Oncology | ||||||
| 07/30/2024 | Janssen Global Services, LLC | ERLEADA (Drug) | Consulting Fee | Cash or cash equivalent | $5,500.00 | General |
| Category: Oncology | ||||||
| 06/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Consulting Fee | Cash or cash equivalent | $2,100.00 | General |
| Category: Oncology | ||||||
| 04/04/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $121.38 | General |
| Category: ONCOLOGY | ||||||
| 02/07/2024 | Janssen Scientific Affairs, LLC | — | Travel and Lodging | In-kind items and services | $2,211.93 | General |
| 02/02/2024 | Astellas Pharma Global Development | Xtandi (Drug) | Consulting Fee | Cash or cash equivalent | $1,185.00 | General |
| Category: Oncology | ||||||
| 01/10/2024 | Eisai Inc. | Lenvima (Drug) | Consulting Fee | Cash or cash equivalent | $2,205.00 | General |
| Category: Oncology | ||||||
| 01/10/2024 | Eisai Inc. | Lenvima (Drug) | Travel and Lodging | Cash or cash equivalent | $341.95 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 212 | 462 | $137,639 | $42,785 |
| 2022 | 6 | 282 | 498 | $140,942 | $46,795 |
| 2021 | 5 | 233 | 455 | $129,273 | $47,567 |
| 2020 | 4 | 223 | 474 | $141,763 | $42,427 |
Total Patients
950
Total Services
1,889
Medicare Billing
$179,573
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 80 | 212 | $66,820 | $21,039 | 31.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 56 | 149 | $47,162 | $14,745 | 31.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 45 | 60 | $14,055 | $4,112 | 29.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 31 | 41 | $9,602 | $2,889 | 30.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 83 | 187 | $56,281 | $19,411 | 34.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 59 | 139 | $41,592 | $14,328 | 34.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 19 | 19 | $8,133 | $2,907 | 35.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 19 | 19 | $8,181 | $2,440 | 29.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 12 | 28 | $6,148 | $2,214 | 36.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 13 | 13 | $5,598 | $1,720 | 30.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 20 | 24 | $5,357 | $1,686 | 31.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 12 | 12 | $2,674 | $765.44 | 28.6% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 2022 | 25 | 32 | $3,959 | $749.18 | 18.9% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2022 | 20 | 25 | $3,020 | $573.69 | 19.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 75 | 195 | $57,057 | $21,900 | 38.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 67 | 140 | $40,964 | $15,979 | 39.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 21 | 46 | $9,844 | $3,452 | 35.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 14 | 15 | $6,256 | $2,221 | 35.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 25 | 27 | $5,859 | $1,529 | 26.1% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 11 | 11 | $4,736 | $1,272 | 26.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 20 | 21 | $4,557 | $1,213 | 26.6% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 96 | 241 | $70,517 | $20,516 | 29.1% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 78 | 172 | $50,327 | $14,626 | 29.1% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 15 | 15 | $6,459 | $2,043 | 31.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 12 | 24 | $5,136 | $2,019 | 39.3% |
About Dr. Benjamin Maughan, MD
Dr. Benjamin Maughan, MD is a Student in an Organized Health Care Education/Training Program healthcare provider based in Salt Lake City, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/02/2010. The National Provider Identifier (NPI) number assigned to this provider is 1255656120.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Benjamin Maughan, MD has received a total of $138,156 in payments from pharmaceutical and medical device companies, with $24,327 received in 2024. These payments were reported across 195 transactions from 23 companies. The most common payment nature is "Consulting Fee" ($89,109).
As a Medicare-enrolled provider, Maughan has provided services to 950 Medicare beneficiaries, totaling 1,889 services with total Medicare billing of $179,573. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Hematology & Oncology
- Location Salt Lake City, UT
- Active Since 04/02/2010
- Last Updated 11/20/2021
- Taxonomy Code 390200000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1255656120
Products in Payments
- Nubeqa (Drug) $22,256
- ERLEADA (Drug) $9,634
- Cabometyx (Drug) $9,570
- XTANDI (Drug) $8,071
- Erleada (Drug) $7,537
- Non-Covered (Drug) $7,150
- JEVTANA (Drug) $6,133
- OPDIVO (Biological) $5,542
- Lenvima (Drug) $4,945
- Xofigo (Drug) $4,877
- Xtandi (Drug) $4,362
- CABOMETYX (Drug) $4,001
- Non-Covered Product (Drug) $2,650
- FOTIVDA (Drug) $2,041
- Rubraca (Drug) $1,096
- ILLUCCIX (Drug) $968.11
- KEYTRUDA (Biological) $610.77
- WELIREG (Drug) $610.00
- KEYTRUDA (Drug) $572.05
- Bavencio (Drug) $255.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Salt Lake City
Dr. Guilherme Santos Piedade, Md, Phd, MD, PHD
Student in an Organized Health Care Education/Training Program — Payments: $49,296
Student in an Organized Health Care Education/Training Program $49,296
Vikas Sharma, Mbbs, MBBS
Student in an Organized Health Care Education/Training Program — Payments: $19,118
Student in an Organized Health Care Education/Training Program $19,118
Elizabeth Chabot, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $14,376
Student in an Organized Health Care Education/Training Program $14,376
Dr. Lee Linstroth, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $13,541
Student in an Organized Health Care Education/Training Program $13,541
Joseph Armstrong, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $8,110
Student in an Organized Health Care Education/Training Program $8,110
Brian Zaugg, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $7,774
Student in an Organized Health Care Education/Training Program $7,774